Last10K.com

Qiagen Nv (QGEN) SEC Filing 20-F Annual report for the fiscal year ending Monday, December 31, 2012

Qiagen Nv

CIK: 1015820 Ticker: QGEN

View differences made from one year to another to evaluate Qiagen Nv's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Qiagen Nv.

Continue

Assess how Qiagen Nv's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Qiagen Nv's Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets Parenthetical
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Equity
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Income
Accrued And Other Liabilities
Accrued And Other Liabilities (details)
Accrued And Other Liabilities (tables)
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (details)
Accumulated Other Comprehensive Income (tables)
Acquisitions
Acquisitions (tables)
Acquisitions Acquisitions - Narrative (details)
Acquisitions Acquisitions - Purchase Price (details)
Commitments And Contingencies
Commitments And Contingencies (narrative) (details)
Commitments And Contingencies (schedule Of Commitments To Purchase Goods Or Services And For Future Minimum Guaranteed Royalties) (details)
Commitments And Contingencies (schedule Of Minimum Future Obligations Under Capital And Operating Leases) (details)
Commitments And Contingencies (tables)
Corporate Information And Basis Of Presentation
Corporate Information And Basis Of Presentation (details)
Derivatives And Hedging
Derivatives And Hedging (fair Value Amounts Of Derivative Instruments) (details)
Derivatives And Hedging (gains And Losses On Derivative Instruments) (details)
Derivatives And Hedging (narrative) (details)
Derivatives And Hedging (tables)
Earnings Per Common Share
Earnings Per Common Share (details)
Earnings Per Common Share (tables)
Effects Of New Accounting Pronouncements (notes)
Effects Of New Accounting Pronouncements (policies)
Employee Benefit Plans
Employee Benefit Plans (details)
Fair Value Measurements
Fair Value Measurements (tables)
Fair Value Measurements - Recurring Basis (details)
Fair Value Measurements Fair Value Measurements - Level 3 Activity (details)
Goodwill And Intangible Assets
Goodwill And Intangible Assets (changes In The Carrying Amount Of Goodwill, By Segment) (details)
Goodwill And Intangible Assets (narrative) (details)
Goodwill And Intangible Assets (schedule Of Amortization Of Intangibles For The Next Five Years) (details)
Goodwill And Intangible Assets (schedule Of Intangible Assets By Major Asset Class) (details)
Goodwill And Intangible Assets (tables)
Income Taxes
Income Taxes (changes In Gross Amounts Of Unrecognized Tax Benefits) (details)
Income Taxes (components Of Net Deferred Tax Liabilities) (details)
Income Taxes (income Before Income Taxes) (details)
Income Taxes (narrative) (details)
Income Taxes (provision For Income Taxes) (details)
Income Taxes (statutory Rate And Effective Tax Rate) (details)
Income Taxes (tables)
Investments
Investments (narrative) (details)
Investments (summary Of Investments Included In Other Assets) (details)
Investments (tables)
Lines Of Credit And Debt
Lines Of Credit And Debt (narrative) (details)
Lines Of Credit And Debt (schedule Of Maturities Of Long-term Debt) (details)
Lines Of Credit And Debt (schedule Of Total Debt Instruments) (details)
Lines Of Credit And Debt (tables)
Prepaid Expenses And Other Current Assets
Prepaid Expenses And Other Current Assets (details)
Prepaid Expenses And Other Current Assets (tables)
Property, Plant And Equipment
Property, Plant And Equipment (details)
Property, Plant And Equipment (narrative) (details)
Property, Plant And Equipment (tables)
Related Party Transactions
Related Party Transactions (narrative) (details)
Related Party Transactions (schedule Of Related Party Transactions) (details)
Related Party Transactions (tables)
Restructuring
Restructuring (details)
Restructuring (tables)
Restructuring - Cash Components (details)
Schedule Ii - Valuation And Qualifying Accounts
Schedule Ii - Valuation And Qualifying Accounts (details)
Segment Information
Segment Information (geographical Information) (details)
Segment Information (long-lived Asset Information) (details)
Segment Information (narrative) (details)
Segment Information (product Category Information) (details)
Segment Information (tables)
Share Repurchase Program (details)
Share Repurchase Program (notes)
Share-based Compensation
Share-based Compensation (narrative) (details)
Share-based Compensation (schedule Of Compensation Expense) (details)
Share-based Compensation (schedule Of Employee Stock Options And Restricted Stock Units) (details)
Share-based Compensation (schedule Of Weighted Average Assumptions Used In Valuing Stock Options Granted To Employees) (details)
Share-based Compensation (tables)
Short-term Investments
Short-term Investments (details)
Subsequent Event (details)
Subsequent Event (notes)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (changes In The Carrying Amount Of Warranty Obligations) (details)
Summary Of Significant Accounting Policies (inventories) (details)
Summary Of Significant Accounting Policies (narrative) (details)
Summary Of Significant Accounting Policies (policy)
Summary Of Significant Accounting Policies (tables)
Ticker: QGEN
CIK: 1015820
Form Type: 20-F Annual Report
Accession Number: 0001015820-13-000005
Submitted to the SEC: Fri Mar 01 2013 6:00:18 PM EST
Accepted by the SEC: Mon Mar 04 2013
Period: Monday, December 31, 2012
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/qgen/0001015820-13-000005.htm